Extra virgin olive oil
Intervention1 paper3 findings
- Human trial1
Outcomes
3HbA1c
downin humans1Low certainty
1 study
HbA1c
downin humans1Low certainty
Extra virgin olive oil decreases HbA1c in humans (β = -0.13%; 95% CI: -0.25, -0.01).
Human trialcompared with regular olive oil0.7 g/kg/day4 weeksn = 28
Corbella Extra Virgin Olive Oil, Urinary Phenolic Metabolites, and Exploratory Cardiometabolic Outcomes in Healthy Young Adults: The HEVOOC Trial · Antioxidants (Basel, Switzerland) · 19 Aug 2026
Waist circumference
downin humans1Low certainty
1 study
Waist circumference
downin humans1Low certainty
Extra virgin olive oil decreases waist circumference in humans (β = -2.21 cm; 95% CI: -3.37, -1.05).
Human trialcompared with regular olive oil0.7 g/kg/day4 weeksn = 28
Corbella Extra Virgin Olive Oil, Urinary Phenolic Metabolites, and Exploratory Cardiometabolic Outcomes in Healthy Young Adults: The HEVOOC Trial · Antioxidants (Basel, Switzerland) · 19 Aug 2026
Hydroxytyrosol-glucuronide
upin humans1Low certainty
1 study
Hydroxytyrosol-glucuronide
upin humans1Low certainty
Extra virgin olive oil increases hydroxytyrosol-glucuronide in humans (GMR = 9.9; 95% CI: 2.0, 49.0; p = 0.005).
Human trialcompared with regular olive oil0.7 g/kg/day4 weeksn = 28
Corbella Extra Virgin Olive Oil, Urinary Phenolic Metabolites, and Exploratory Cardiometabolic Outcomes in Healthy Young Adults: The HEVOOC Trial · Antioxidants (Basel, Switzerland) · 19 Aug 2026